Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia. 2023

O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
Galdakao-Usansolo University Hospital, Pulmonology Department, Galdakao, Spain; BioCruces Bizkaia Health Research Institute, Baracaldo, Spain. Electronic address: obronte001@ikasle.ehu.eus.

The relationship between exposure to air pollution and the severity of coronavirus disease 2019 (COVID-19) pneumonia and other outcomes is poorly understood. Beyond age and comorbidity, risk factors for adverse outcomes including death have been poorly studied. The main objective of our study was to examine the relationship between exposure to outdoor air pollution and the risk of death in patients with COVID-19 pneumonia using individual-level data. The secondary objective was to investigate the impact of air pollutants on gas exchange and systemic inflammation in this disease. This cohort study included 1548 patients hospitalised for COVID-19 pneumonia between February and May 2020 in one of four hospitals. Local agencies supplied daily data on environmental air pollutants (PM10, PM2.5, O3, NO2, NO and NOX) and meteorological conditions (temperature and humidity) in the year before hospital admission (from January 2019 to December 2019). Daily exposure to pollution and meteorological conditions by individual postcode of residence was estimated using geospatial Bayesian generalised additive models. The influence of air pollution on pneumonia severity was studied using generalised additive models which included: age, sex, Charlson comorbidity index, hospital, average income, air temperature and humidity, and exposure to each pollutant. Additionally, generalised additive models were generated for exploring the effect of air pollution on C-reactive protein (CRP) level and SpO2/FiO2 at admission. According to our results, both risk of COVID-19 death and CRP level increased significantly with median exposure to PM10, NO2, NO and NOX, while higher exposure to NO2, NO and NOX was associated with lower SpO2/FiO2 ratios. In conclusion, after controlling for socioeconomic, demographic and health-related variables, we found evidence of a significant positive relationship between air pollution and mortality in patients hospitalised for COVID-19 pneumonia. Additionally, inflammation (CRP) and gas exchange (SpO2/FiO2) in these patients were significantly related to exposure to air pollution.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D009585 Nitrogen Dioxide Nitrogen oxide (NO2). A highly poisonous gas. Exposure produces inflammation of lungs that may only cause slight pain or pass unnoticed, but resulting edema several days later may cause death. (From Merck, 11th ed) It is a major atmospheric pollutant that is able to absorb UV light that does not reach the earth's surface. Nitrogen Peroxide,Dioxide, Nitrogen,Peroxide, Nitrogen
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000393 Air Pollutants Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS. Air Pollutant,Air Pollutants, Environmental,Environmental Air Pollutants,Environmental Pollutants, Air,Air Environmental Pollutants,Pollutant, Air,Pollutants, Air,Pollutants, Air Environmental,Pollutants, Environmental Air
D000397 Air Pollution The presence of contaminants or pollutant substances in the air (AIR POLLUTANTS) that interfere with human health or welfare, or produce other harmful environmental effects. The substances may include GASES; PARTICULATE MATTER; or volatile ORGANIC CHEMICALS. Air Quality,Air Pollutions,Pollution, Air
D001499 Bayes Theorem A theorem in probability theory named for Thomas Bayes (1702-1761). In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihood of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result. Bayesian Analysis,Bayesian Estimation,Bayesian Forecast,Bayesian Method,Bayesian Prediction,Analysis, Bayesian,Bayesian Approach,Approach, Bayesian,Approachs, Bayesian,Bayesian Approachs,Estimation, Bayesian,Forecast, Bayesian,Method, Bayesian,Prediction, Bayesian,Theorem, Bayes
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
July 2023, The European respiratory journal,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
January 2020, Global health research and policy,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
December 2020, Medical hypotheses,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
July 2020, The Journal of allergy and clinical immunology,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
December 2022, Environmental research,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
January 2021, Air quality, atmosphere, & health,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
March 2021, European respiratory review : an official journal of the European Respiratory Society,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
January 2024, Journal of thoracic disease,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
July 2021, American journal of respiratory and critical care medicine,
O Bronte, and F García-García, and D-J Lee, and I Urrutia, and A Uranga, and M Nieves, and J Martínez-Minaya, and J M Quintana, and I Arostegui, and R Zalacain, and L A Ruiz-Iturriaga, and L Serrano, and R Menéndez, and R Méndez, and A Torres, and C Cilloniz, and P P España, and
May 2023, Journal of environmental economics and management,
Copied contents to your clipboard!